Actively Recruiting
Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)
Led by First Affiliated Hospital Xi'an Jiaotong University · Updated on 2024-07-12
40
Participants Needed
1
Research Sites
352 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to retrospectively and prospectively collect clinical and biological specimen data from patients with cardiac tumors who meet the inclusion and exclusion criteria. Various techniques, including general molecular biology analysis and multi-omics analysis, will be used to construct a prognostic model for cardiac tumors.
CONDITIONS
Official Title
Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must be regularly seen and followed up in a cardiovascular center
- Patients must have at least one diagnosed type of cardiac tumor: myxoma, fibroma, lipoma, hemangioma, undifferentiated sarcoma, angiosarcoma, rhabdomyosarcoma, lymphoma, cardiac metastasis, or other cardiac tumors
You will not qualify if you...
- Age under 3 years or over 80 years
- Pregnant or breastfeeding women
- Patients who refuse to provide informed consent
- Patients unable to sign informed consent due to coma or lack of legal representative
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital of Xi'an Jiantong University
Xi'an, Shaanxi, China, 710061
Actively Recruiting
Research Team
G
Guoliang Li
CONTACT
Y
Yang Yan
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here